ARTICLE | Company News
Ambry Genetics, Myriad Genetics diagnostic news
December 22, 2014 8:00 AM UTC
The U.S. Court of Appeals for the Federal Circuit (CAFC) ruled that a district court correctly denied Myriad’s motion for preliminary injunction against Ambry for Ambry’s standalone breast cancer 1 e...